Inhaled Albuterol

PreclinicalSmall molecule

NNational Heart, Lung, and Blood Institute (NHLBI)

Inhaled Albuterol is one of 35 small molecule programs targeting Wheezing. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

WheezingActive, not recruiting

AsthmaActive, not recruiting

WheezingPreclinical

Active, not recruiting

AsthmaPreclinical

Active, not recruiting

Competition

Competitive Landscape

175 competitors in Asthma

#DrugCompanyPhaseTrials

Celexa

AbbVie

Preclinical

1 2

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

1 3

DUPIXENT

Regeneron

Preclinical

1 4

Paracetamol

GSK

Preclinical

1 5

Blood Withdrawn

Emergent BioSolutions

Preclinical

1 6

Aclidinium Bromide

AstraZeneca

Preclinical

—7

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 8

Lexapro

SShirley Ryan AbilityLab

Preclinical

1 9

Biological Drug

UUniversitaire Ziekenhuizen KU Leuven

Preclinical

1 10

Guanidine Hydrochloride

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma2 trials

Changes in the Lung Clearance Index in Pediatric Patients With Asthma

Unknown status·HHospital Infantil de Mexico Federico Gomez·N/A·NCT02678949·105 enrolled

Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·N/A·NCT00319488·238 enrolled

Wheezing1 trial

Treatment of Persistent Wheezing in Infants and Children

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·N/A·NCT00301171·54 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Inhaled Albuterol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inhaled Albuterol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inhaled Albuterol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Heart, Lung, and Blood Institute (NHLBI) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Heart, Lung, and Blood Institute (NHLBI)

Inhaled Albuterol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma2 trials

Wheezing1 trial

References

Drug Info

Quick Facts

Related News